Advertisement
Screener

Dimension Therapeutics, Inc. Patents: Applications Pending

Dimension Therapeutics, Inc. Patent Applications Pending

10 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2018-12-18: Application 62781380; Invention METHODS AND COMPOSITIONS FOR TREATING GLYCOGEN STORAGE DISEASES; Applicant Dimension Therapeutics, Inc.; Status Provisional Application Expired.
  • 2017-10-13: Application PCTUS2017056588; Invention USE OF TONICIFYING AGENTS TO ENHANCE RECOMBINANT ADENO-ASSOCIATED VIRUS YIELD; Applicant DIMENSION THERAPEUTICS, INC.; Status PCT - International Search Report Mailed to IB.
  • 2017-07-12: Application PCTUS2017041738; Invention USE OF GLUCOCORTICOID ANALOGS TO ENHANCE RECOMBINANT ADENO-ASSOCIATED VIRUS YIELD; Applicant DIMENSION THERAPEUTICS, INC; Status PCT - International Search Report Mailed to IB.
  • 2017-05-09: Application 62503660; Invention SCALABLE METHOD FOR PRODUCING TRANSFECTION REAGENTS; Applicant Dimension Therapeutics, Inc.; Status Provisional Application Expired.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2018-12-1862781380METHODS AND COMPOSITIONS FOR TREATING GLYCOGEN STORAGE DISEASESDimension Therapeutics, Inc.Provisional Application Expired
Christopher Tipper
Kelly Reed Clark
Samuel Wadsworth
United States
United States
United States
2017-10-13PCTUS2017056588USE OF TONICIFYING AGENTS TO ENHANCE RECOMBINANT ADENO-ASSOCIATED VIRUS YIELDDIMENSION THERAPEUTICS, INC.PCT - International Search Report Mailed to IB
YING JING
JAN PANTELI
United States
United States
YOUNG, LEE W
2017-07-12PCTUS2017041738USE OF GLUCOCORTICOID ANALOGS TO ENHANCE RECOMBINANT ADENO-ASSOCIATED VIRUS YIELDDIMENSION THERAPEUTICS, INCPCT - International Search Report Mailed to IB
MINGYANG JIANG
YING JING
KELLY R. CLARK
United States
United States
United States
THOMAS, SHANE M
2017-05-0962503660SCALABLE METHOD FOR PRODUCING TRANSFECTION REAGENTSDimension Therapeutics, Inc.Provisional Application Expired
Jan Panteli
Ying Jing
United States
United States
2017-03-28PCTUS2017024545METHODS OF HEAT INACTIVATION OF ADENOVIRUSDIMENSION THERAPEUTICS, INC.PCT - International Search Report Mailed to IB
CHRISTOPHER J. MORRISON
JAMES D. MARATT
United States
United States
THOMAS, SHANE M
2017-03-2262475112CELL CULTURE METHODS INVOLVING HDAC INHIBITORS OR REP PROTEINSDimension Therapeutics, Inc.Provisional Application Expired
Aubrey Tiernan
Christopher Tipper
United States
United States
2017-03-2262474932METHODS FOR ENHANCING CLARIFICATION YIELD OF RECOMBINANT ADENO-ASSOCIATED VIRUSDimension Therapeutics, Inc.Provisional Application Expired
Ying Jing
Jan Panteli
Kelly Reed Clark
United States
United States
United States
2016-10-1462408420USE OF TONICIFYING AGENTS TO ENHANCE RECOMBINANT ADENO-ASSOCIATED VIRUS YIELDDimension Therapeutics, Inc.Provisional Application Expired
Ying Jing
Jan Panteli
United States
United States
2016-07-1262361098USE OF GLUCOCORTICOID ANALOGS TO ENHANCE RECOMBINANT ADENO-ASSOCIATED VIRUS YIELDDimension Therapeutics, Inc.Provisional Application Expired
Ying Jing
Mingyang Jiang
Kelly Reed Clark
United States
United States
United States
2016-03-2862314116Methods of Heat Inactivation of AdenovirusDimension Therapeutics, Inc.Provisional Application Expired
Christopher J. Morrison
James D. Maratt
United States
United States